Celltrion Obtains 5 ISO Certifications Including Quality and Anti-Corruption... "Strengthening Global Competitiveness"

Shin Min-cheol, Head of Management Division at Celltrion (right), and Lim Seong-hwan, CEO of BSI Korea, are conducting the ISO integrated certification award ceremony and taking a commemorative photo.

[Asia Economy Reporter Lee Gwan-joo] Celltrion announced on the 14th that it has acquired multiple international standard certifications established by the International Organization for Standardization (ISO) to strengthen its global business competitiveness.

Since 2020, Celltrion has sequentially obtained five international standard certifications including ISO 9001 (Quality Management System), ISO 14001 (Environmental Management System), ISO 45001 (Occupational Health and Safety Management System), ISO 37001 (Anti-Bribery Management System), and ISO 22301 (Business Continuity Management System) to enhance ESG (Environmental, Social, and Governance) management and grow as a sustainable pharmaceutical and bio company.

Celltrion introduced the globally most widely adopted representative quality management system (ISO 9001) certification to improve high-level quality and customer satisfaction. Through the operation and improvement of the quality management system, the company plans to continuously enhance pharmaceutical quality in response to the changing business environment and secure competitiveness in the international pharmaceutical bidding market to promote customer satisfaction.

Additionally, by acquiring certifications for the Environmental Management System (ISO 14001) and Occupational Health and Safety Management System (ISO 45001), Celltrion efficiently manages resources and the environment and applies standardized safety and health regulations and procedures at its workplaces. With the introduction of the Anti-Bribery Management System (ISO 37001), the company has established a company-wide compliance management system and effectively prevents various corruption risks such as internal and external corruption risk assessments.

The Business Continuity Management System (ISO 22301) is an international standard certification that evaluates the ability to quickly restore business activities when business interruptions occur due to various risk factors such as natural disasters, fires, supply chain disruptions, and wars. Celltrion plans to establish a continuous inspection and monitoring system to ensure stable pharmaceutical production during crisis situations and to continuously monitor internal and external factors.

A Celltrion official said, “As a result of efforts to build a global-level management system and carry out management activities that meet the demands of various stakeholders, we have acquired international standard certifications in areas such as quality, environment, occupational health and safety, anti-corruption, and business continuity. We will continue to strengthen ESG management activities and do our best to enhance global market competitiveness to grow as a sustainable pharmaceutical and bio company.”

This content was produced with the assistance of AI translation services.